Accelerate Diagnostics Inc reports results for the quarter ended in March - Earnings Summary

Accelerate Diagnostics

17/05/2022 01:13

* Accelerate Diagnostics Inc  AXDX.OQ  reported a quarterly
adjusted loss of 21 cents​​ per share for the quarter ended in
March. The mean expectation of two analysts for the quarter was
for a loss of 30 cents per share.
    * Revenue rose 17.5% to $2.96 million from a year ago; 
analysts
expected $2.95 million. 
    * Accelerate Diagnostics Inc's reported EPS for the quarter
was a
loss of 21 cents​.
    * The mean earnings estimate of analysts had risen by
about 1.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Accelerate Diagnostics Inc shares had fallen by 52.1% this
quarter and lost 86.8% so far this year.
    * The company reported a quarterly loss of $14.19 million.
    * Wall Street's median 12-month price target for Accelerate
Diagnostics Inc is $5.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 17 at 12:13 a.m.  ​All
figures in US dollars unless otherwise stated